Clinical trial
Efficacy and Safety of Imatinib and Vinorelbine in Patients With Advanced Breast…
NCT00372476 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00372476 |
|---|---|
| Title | Efficacy and Safety of Imatinib and Vinorelbine in Patients With Advanced Breast Cancer |
| Official title | Open-label Trial of Imatinib in Combination With Vinorelbine for Patients With Advanced Breast Carcinoma: ICON |
| Acronym | INV181 |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Imatinib and Vinorelbine |
| Enrollment | 33 |
| Start date | Jun 1, 2006 |
| Primary completion | Jul 1, 2012 |
| Completion | Jul 1, 2012 |
| First posted | Sep 7, 2006 |
| Last update posted | Feb 7, 2017 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: